Choksi Laboratories Ltd

CHOKSILA Share Price

BSE

₹111.000.91% (+1.00)

Health Care

Labs & Life Sciences Services

Smallcap

With a market cap of ₹77 cr, stock is ranked 3,365

High Risk

Stock is 4.53x as volatile as Nifty

CHOKSILA Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health Care

Labs & Life Sciences Services

Smallcap

With a market cap of ₹77 cr, stock is ranked 3,365

High Risk

Stock is 4.53x as volatile as Nifty

CHOKSILA Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
41.33	3.27	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
36.86	5.82	0.58%

CHOKSILA Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

CHOKSILA Company Profile

Choksi Laboratories Ltd provides contract testing and analytical services for pharmaceuticals, food, and environmental monitoring, ensuring compliance and quality assurance.

CHOKSILA Similar Stocks (Peers)

Compare with peers Compare with peers

CHOKSILA Similar Stocks (Peers)

Compare with peers Compare with peers

Divi's Laboratories Ltd

DIVISLAB

PE Ratio

77.65

1Y Return

14.12%

Buy Reco %

62.50

Syngene International Ltd

SYNGENE

PE Ratio

34.18

1Y Return

37.66%

Buy Reco %

66.67

Aarti Pharmalabs Ltd

AARTIPHARM

PE Ratio

24.09

1Y Return

2.24%

Buy Reco %

0.00

Dishman Carbogen Amcis Ltd

DCAL

PE Ratio

847.11

1Y Return

15.25%

Buy Reco %

0.00

Vimta Labs Ltd

VIMTALABS

PE Ratio

29.97

1Y Return

1.13%

Buy Reco %

0.00

Compare with Peers

CHOKSILA Forecast

CHOKSILA Forecasts

CHOKSILA

Income

Balance Sheet

Cash Flow

Financial Year		FY 2017		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	TTM
Total Revenue	29.62	30.77	34.00	28.49	26.18	30.16	37.48	36.86	41.85	45.56
Raw Materials	2.97	3.47	3.95	3.24	2.57	1.98	2.21	2.56	3.10	32.62
Power & Fuel Cost	0.74	0.73	0.77	0.78	0.66	0.70	0.83	0.84	0.99
Employee Cost	8.76	10.51	11.47	11.70	10.78	11.04	12.00	13.03	15.22
Selling & Administrative Expenses	5.45	6.48	7.24	5.96	4.65	4.69	6.06	6.43	7.20
Operating & Other expenses	6.06	2.89	3.06	6.06	2.91	2.72	3.64	3.56	3.97
EBITDA	5.64	6.69	7.51	0.75	4.61	9.03	12.74	10.44	11.37	12.94
Depreciation/Amortization	2.86	3.16	3.68	4.56	4.60	5.43	5.50	5.71	6.50	6.90
PBIT	2.78	3.53	3.83	-3.81	0.01	3.60	7.24	4.73	4.87	6.04
Interest & Other Items	1.47	1.59	1.54	1.89	2.82	3.23	3.52	3.06	2.72	2.68
PBT	1.31	1.94	2.29	-5.70	-2.81	0.37	3.72	1.67	2.15	3.36
Taxes & Other Items	0.42	0.58	0.69	-1.83	-0.20	0.16	0.51	0.55	0.63	1.49
Net Income	0.89	1.36	1.60	-3.87	-2.61	0.21	3.21	1.12	1.52	1.87
EPS	1.28	1.95	2.30	-5.56	-3.75	0.30	4.61	1.61	2.18	2.68
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

CHOKSILA Income Statement

Quarter		sep 2023		dec 2023		mar 2024		jun 2024		sep 2024	dec 2024	mar 2025	jun 2025	sep 2025	dec 2025
Total Revenue	8.00	8.80	11.18	10.74	9.27	10.39	11.44	11.25	11.13	11.74
Operating & Other expenses	5.84	6.55	7.64	7.90	6.90	7.84	7.90	8.34	8.19	8.19
EBITDA	2.16	2.25	3.54	2.84	2.37	2.55	3.54	2.91	2.94	3.55
Depreciation/Amortization	1.41	1.43	1.49	1.50	1.61	1.68	1.70	1.68	1.69	1.83
PBIT	0.75	0.82	2.05	1.34	0.76	0.87	1.84	1.23	1.25	1.72
Interest & Other Items	0.74	0.67	0.77	0.72	0.66	0.69	0.58	0.60	0.69	0.81
PBT	0.01	0.15	1.28	0.62	0.10	0.18	1.26	0.63	0.56	0.91
Taxes & Other Items	0.00	0.08	0.60	0.19	0.02	0.08	0.34	0.24	0.32	0.59
Net Income	0.01	0.07	0.68	0.43	0.08	0.10	0.92	0.39	0.24	0.32
EPS	0.01	0.09	0.98	0.60	0.11	0.15	1.32	0.55	0.35	0.45

Financial Year		FY 2016		FY 2017		FY 2018		FY 2019		FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Cash from Operating Activities	0.01	6.57	6.25	6.91	2.87	5.90	7.88	8.25	11.55	11.78
Cash from Investing Activities	-0.01	-1.88	-4.92	-9.76	-13.76	-7.65	-2.71	-0.71	-6.65	-7.61
Cash from Financing Activities	0.00	-4.89	-0.94	2.13	11.09	1.63	-5.07	-7.61	-4.58	-4.22
Net Change in Cash	+0.00	-0.20	+0.39	-0.72	+0.20	-0.12	+0.10	-0.07	+0.32	-0.05
Changes in Working Capital	+0.00	+1.60	+0.01	-0.40	+1.49	+1.78	-1.21	-2.37	+1.11	+0.19
Capital Expenditures	0.00	3.24	4.95	6.77	1.49	7.59	1.17	4.13	4.44	7.69
Free Cash Flow	0.01	3.33	1.30	0.14	1.38	-1.69	6.71	4.12	7.11	4.09

CHOKSILA Company Updates

FY 2025FY 2025

Annual report

PDF

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

FY 2016FY 2016

Annual report

PDF

CHOKSILA Stock Peers

CHOKSILA Past Performance & Peer Comparison

Comparing 3 stocks from
Health CareLabs & Life Sciences Services

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Choksi Laboratories Ltd	50.84	3.27	—
Divi's Laboratories Ltd	77.65	11.37	0.47%
Syngene International Ltd	34.18	3.59	0.30%
Aarti Pharmalabs Ltd	24.09	3.30	0.69%

CHOKSILA Stock Price Comparison

Compare CHOKSILA with any stock or ETF

CHOKSILA

CHOKSILA Holdings

CHOKSILA Shareholdings

CHOKSILA Promoter Holdings Trend

CHOKSILA Institutional Holdings Trend

CHOKSILA Shareholding Pattern

CHOKSILA Shareholding History

Foreign Institutions

CHOKSILA Insider Trades & Bulk Stock Deals

smallcases containing CHOKSILA stock

Looks like this stock is not in any smallcase yet.

CHOKSILA Events

CHOKSILA Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

CHOKSILA Dividend Trend

CHOKSILA Dividends

Hmm, looks like data is unavailable here. Please come back after some time

CHOKSILA Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming announcements are available

Company Update

Announced OnFeb 9, 2026

Choksi Laboratories Ltd - 526546 - Annou

Choksi Laboratories Ltd - 526546 - Annou Download

Link

Download

Announced On

Feb 9, 2026

Company Update

Announced OnFeb 7, 2026

Choksi Laboratories Ltd - 526546 - Intim

Choksi Laboratories Ltd - 526546 - Intim Download

Link

Download

Announced On

Feb 7, 2026

Company Update

Announced OnFeb 7, 2026

Choksi Laboratories Ltd - 526546 - Annou

Choksi Laboratories Ltd - 526546 - Annou Download

Link

Download

Announced On

Feb 7, 2026

Result

Announced OnFeb 7, 2026

Choksi Laboratories Ltd - 526546 - Finan

Choksi Laboratories Ltd - 526546 - Finan Download

Link

Download

Announced On

Feb 7, 2026

Board Meeting

Announced OnFeb 7, 2026

Choksi Laboratories Ltd - 526546 - Board

Choksi Laboratories Ltd - 526546 - Board Download

Link

Download

Announced On

Feb 7, 2026

CHOKSILA Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

CHOKSILA Stock News & Opinions

Earnings

Choksi Laboratories standalone net profit rises 181.82% in the December 2025 quarter

Net profit of Choksi Laboratories rose 181.82% to Rs 0.31 crore in the quarter ended December 2025 as against Rs 0.11 crore during the previous quarter ended December 2024. Sales rose 4.24% to Rs 10.82 crore in the quarter ended December 2025 as against Rs 10.38 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales10.8210.38 4 OPM %24.3124.57 - PBDT1.951.87 4 PBT0.120.19 -37 NP0.310.11 182 Powered by Capital Market - Live

2 weeks agoCapital Market - Live

Corporate

Choksi Laboratories declare Quarterly Result

Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 7 February 2026.Powered by Capital Market - Live

3 weeks agoCapital Market - Live

Earnings

Choksi Laboratories standalone net profit rises 200.00% in the September 2025 quarter

Net profit of Choksi Laboratories rose 200.00% to Rs 0.24 crore in the quarter ended September 2025 as against Rs 0.08 crore during the previous quarter ended September 2024. Sales rose 20.09% to Rs 11.12 crore in the quarter ended September 2025 as against Rs 9.26 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales11.129.26 20 OPM %26.3525.49 - PBDT2.251.71 32 PBT0.560.10 460 NP0.240.08 200 Powered by Capital Market - Live

3 months agoCapital Market - Live

Corporate

Choksi Laboratories to discuss results

Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live

Corporate

Choksi Laboratories to conduct AGM

Choksi Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 16 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Earnings

Choksi Laboratories standalone net profit declines 7.14% in the June 2025 quarter

Net profit of Choksi Laboratories declined 7.14% to Rs 0.39 crore in the quarter ended June 2025 as against Rs 0.42 crore during the previous quarter ended June 2024. Sales rose 4.66% to Rs 11.24 crore in the quarter ended June 2025 as against Rs 10.74 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales11.2410.74 5 OPM %25.8926.26 - PBDT2.312.11 9 PBT0.630.61 3 NP0.390.42 -7 Powered by Capital Market - Live

6 months agoCapital Market - Live

Corporate

Choksi Laboratories to discuss results

Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Earnings

Choksi Laboratories standalone net profit rises 35.29% in the March 2025 quarter

Net profit of Choksi Laboratories rose 35.29% to Rs 0.92 crore in the quarter ended March 2025 as against Rs 0.68 crore during the previous quarter ended March 2024. Sales rose 2.52% to Rs 11.40 crore in the quarter ended March 2025 as against Rs 11.12 crore during the previous quarter ended March 2024. For the full year,net profit rose 36.94% to Rs 1.52 crore in the year ended March 2025 as against Rs 1.11 crore during the previous year ended March 2024. Sales rose 13.84% to Rs 41.78 crore in the year ended March 2025 as against Rs 36.70 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales11.4011.12 3 41.7836.70 14 OPM %30.7031.29 -26.8827.85 - PBDT2.962.77 7 8.657.37 17 PBT1.261.28 -2 2.151.66 30 NP0.920.68 35 1.521.11 37 Powered by Capital Market - Live

8 months agoCapital Market - Live

Corporate

Choksi Laboratories to discuss results

Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 7 June 2025.Powered by Capital Market - Live

8 months agoCapital Market - Live

Corporate

Choksi Laboratories to discuss results

Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

What is the share price of Choksi Laboratories Ltd (CHOKSILA) today?
The share price of CHOKSILA as on 27th February 2026 is ₹111. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Choksi Laboratories Ltd (CHOKSILA) share?
The past returns of Choksi Laboratories Ltd (CHOKSILA) share are
- Past 1 week: 1.83%
- Past 1 month: -7.50%
- Past 3 months: -18.63%
- Past 6 months: -46.34%
- Past 1 year: -8.68%
- Past 3 years: 187.81%
- Past 5 years: 1131.41%
What are the peers or stocks similar to Choksi Laboratories Ltd (CHOKSILA)?
The peers or stocks similar to Choksi Laboratories Ltd (CHOKSILA) include:
What is the market cap of Choksi Laboratories Ltd (CHOKSILA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Choksi Laboratories Ltd (CHOKSILA) is ₹77.28 Cr as of 27th February 2026.
What is the 52 week high and low of Choksi Laboratories Ltd (CHOKSILA) share?
The 52-week high of Choksi Laboratories Ltd (CHOKSILA) is ₹236.70 and the 52-week low is ₹95.
What is the PE and PB ratio of Choksi Laboratories Ltd (CHOKSILA) stock?
The P/E (price-to-earnings) ratio of Choksi Laboratories Ltd (CHOKSILA) is 50.84. The P/B (price-to-book) ratio is 3.27.
Which sector does Choksi Laboratories Ltd (CHOKSILA) belong to?
Choksi Laboratories Ltd (CHOKSILA) belongs to the Health Care sector & Labs & Life Sciences Services sub-sector.
How to buy Choksi Laboratories Ltd (CHOKSILA) shares?
You can directly buy Choksi Laboratories Ltd (CHOKSILA) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Choksi Laboratories Ltd	54.37%	44.06	Pro
Divi's Laboratories Ltd	25.36%	64.91
Syngene International Ltd	30.36%	25.30
Aarti Pharmalabs Ltd	43.54%	29.53

Choksi Laboratories Ltd

CHOKSILA Share Price

CHOKSILA Stock Scorecard

CHOKSILA Performance & Key Metrics

CHOKSILA Performance & Key Metrics

CHOKSILA Analyst Ratings & Forecast

Price Upside

Earnings Growth

Rev. Growth

CHOKSILA Company Profile

CHOKSILA Similar Stocks (Peers)

CHOKSILA Similar Stocks (Peers)

CHOKSILA Forecast

CHOKSILA Forecasts

CHOKSILA